Hoey Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Hoey Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.9K	Buy	26 +3	+13%	+$1.33K	﹤0.01%	246
2026 Q1	$10.3K	Buy	23 +10	+77%	+$4.66K	﹤0.01%	253
2025 Q4	$5.89K	Hold	13	–	–	﹤0.01%	282
2025 Q3	$5.09K	Hold	13	–	–	﹤0.01%	284
2025 Q2	$5.79K	Hold	13	–	–	﹤0.01%	268
2025 Q1	$6.3K	Hold	13	–	–	﹤0.01%	233
2024 Q4	$5.24K	Hold	13	–	–	﹤0.01%	233
2024 Q3	$6.09K	Hold	13	–	–	﹤0.01%	237
2024 Q2	$6.09K	Hold	13	–	–	﹤0.01%	237
2024 Q1	$5.43K	Hold	13	–	–	﹤0.01%	238
2023 Q4	$5.29K	Hold	13	–	–	﹤0.01%	243
2023 Q3	$4.52K	Hold	13	–	–	﹤0.01%	255
2023 Q2	$4.58K	Hold	13	–	–	﹤0.01%	255
2023 Q1	$4.1K	Sell	13 -200	-94%	-$60K	﹤0.01%	264
2022 Q4	$61.5K	Hold	213	–	–	0.03%	121
2022 Q3	$62K	Buy	213 +200	+1,538%	+$57.5K	0.02%	131
2022 Q2	$4K	Hold	13	–	–	﹤0.01%	231
2022 Q1	$3K	Buy	+13	New	+$3.08K	﹤0.01%	220

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Hoey Investments's VRTX Position: Q2 2026 in Review

Hoey Investments increased its Vertex Pharmaceuticals (VRTX) stake by 13% in Q2 2026, buying an estimated $1.33K and bringing the position to 26 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #246.

Hoey Investments first reported a position in VRTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $62K in Q3 2022. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Hoey Investments held 26 shares of Vertex Pharmaceuticals worth $12.9K as of Q2 2026.
Hoey Investments bought 3 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.33K.
Vertex Pharmaceuticals made up ﹤0.01% of Hoey Investments's portfolio in Q2 2026, its #246 holding.
Hoey Investments first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
Hoey Investments's Vertex Pharmaceuticals position peaked at $62K in Q3 2022.
1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hoey Investments's 13F filing for Q2 2026, filed 27 Jul 2026.